Use of Sentinel Cells for the Development of Molecular Tests to Control the Quality of Cryopreservation
|ClinicalTrials.gov Identifier: NCT01904825|
Recruitment Status : Withdrawn
First Posted : July 22, 2013
Last Update Posted : July 22, 2013
The aim is to set up tools that will serve as quality tracers for cryopreservation procedures.
To meet this objective, we have chosen to develop reference samples (sentinel cells) that, in the medium term, can be used as controls to guarantee the quality of preservation for biological samples.
The biological tools and an optimised follow-up strategy will make it possible to validate preservation procedures at the CRB in order to guarantee the perfect stability of samples and the validity of clinical studies.
|Condition or disease|
|Aneurysm of the Abdominal Aorta|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||0 participants|
|Target Follow-Up Duration:||1 Day|
|Study Start Date :||September 2006|
|Actual Primary Completion Date :||August 2009|
|Actual Study Completion Date :||August 2009|
- Quality sentinel cells [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 6 months ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01904825
|Principal Investigator:||Alain BONNIN||CHU Dijon - Biological Resource Center|